Bristol-Myers ($BMY) announced the FDA has approve
Post# of 144503
Posted On: 11/24/2015 9:28:17 AM
Bristol-Myers ($BMY) announced the FDA has approved Opdivo for treating advanced renal cell carcinoma in patients who have received prior anti-angiogeneric therapy. J.M. Smucker ($SJM) announced a selling shareholder will offer 2.86 million shares of its common stock in a secondary offering.
(0)
(0)Scroll down for more posts ▼